Key terms
About ECOR
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ECOR news
Apr 08
8:39am ET
electroCore announces launch of Truvaga Plus for general wellness
Apr 02
8:13am ET
electroCore expands intellectual property portfolio
Mar 14
6:27am ET
Electrocore’s Growth Trajectory: A Buy Rating with Promising Prospects
Mar 13
4:18pm ET
electroCore reports Q4 EPS (61c) vs. ($1.22) last year
Feb 06
8:11am ET
electroCore issued U.S. patent related to systems, methods for treating diseases
Jan 22
1:21pm ET
Analysts’ Top Healthcare Picks: Acurx Pharmaceuticals (ACXP), Champions Oncology (CSBR)
Jan 22
6:13am ET
electroCore price target raised to $15 from $11 at H.C. Wainwright
No recent news articles are available for ECOR
No recent press releases are available for ECOR
ECOR Financials
Key terms
Ad Feedback
ECOR Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ECOR Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
